NASDAQ:GHRS

GH Research PLC Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Biotechnology

$11.80

+0.170 (+1.46%)

At Close: Jun 21, 2024

GH Research PLC Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 GHRS shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About GH Research PLC

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1... GHRS Profile

Golden Star

Ticker	Date	Change	Price
V	Jun 18	0.585%	$273.62
EPD	Jun 18	0.95%	$28.30
USFD	Jun 18	0.565%	$53.14
RGA	Jun 17	1.62%	$203.90
MA	Jun 17	1.50%	$448.11
BR	Jun 17	1.59%	$197.65
^DJI	Jun 17	0.92%	38,778.10 points
SARK	Jun 17	1.85%	$30.34
DRI	Jun 14	3.02%	$148.78
BXSL	Jun 14	1.56%	$31.33

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In